Insulet Corporation (PODD) Financials

PODD Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.6 billion 1.9 billion
2023-09-30 2.5 billion 1.9 billion
2023-06-30 2.4 billion 1.8 billion
2023-03-31 2.3 billion 1.8 billion

PODD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 13.3 million 12.6 million
2023-09-30 33.6 million 10.5 million
2023-06-30 25.9 million 13.1 million
2023-03-31 -36.6 million 12.1 million

PODD Net Income

No data available :(

PODD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 704.2 million - -
2023-09-30 685.4 million - -
2023-06-30 660.1 million 1.4 billion -
2023-03-31 620.7 million 1.4 billion -

PODD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 69.9 million
2023-09-30 73.6 million
2023-06-30 70.1 million
2023-03-31 70.1 million

PODD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 31.6 million 42.0 million 212.8 million -
2023-09-30 22.4 million 57.8 million 180.7 million -
2023-06-30 18.1 million 55.1 million 178.7 million -
2023-03-31 37.1 million 50.1 million 162.7 million -

PODD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 509.8 million 148.6 million
2023-09-30 432.7 million 139.4 million
2023-06-30 396.5 million 131.6 million
2023-03-31 358.1 million 117.6 million

PODD

Price: $174.43

52 week price:
125.82
335.91

Earnings Per Share: 2.94 USD

P/E Ratio: 109.83

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 334800

Ebitda: 6.4 million

Market Capitalization: 12.4 billion

Links: